tiprankstipranks
Trending News
More News >
Hightide Therapeutics Inc (HK:2511)
:2511
Hong Kong Market

Compare Hightide Therapeutics Inc (2511) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Hightide Therapeutics Inc
HK$3.05
HK$1.36B
-3.85
135.09%
Brii Biosciences Limited
HK$1.44
HK$1.09B
-2.71
34.82%
Genor Biopharma Holdings Limited
HK$3.06
HK$5.02B
56.31
32.98%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.18B
392.38
116.84%
JW (Cayman) Therapeutics Co. Ltd.
HK$2.50
HK$1.01B
-1.48
74.10%
Mabpharm Limited
HK$0.50
HK$2.23B
-75.00
100.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2511
Hightide Therapeutics Inc
2.68
1.55
137.17%
HK:2137
Brii Biosciences Limited
1.51
0.43
39.81%
HK:6998
Genor Biopharma Holdings Limited
2.50
0.62
32.98%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.12
2.28
123.91%
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
2.42
1.01
71.63%
HK:2181
Mabpharm Limited
0.54
0.26
92.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts